NCT07417176 Persistent COVID-19 Registry in Navarre.
| NCT ID | NCT07417176 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundacion Miguel Servet |
| Condition | Long COVID Symptoms |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-01-04 |
| Primary Completion | 2026-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2021-01-04 with a primary completion date of 2026-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to deepen our understanding of long COVID by determining the prevalence of the main complications and medium- to long-term sequelae of COVID-19 in Navarre. Sociodemographic variables such as age, sex, ethnicity, smoking history, and comorbidities will be collected, as well as clinical and disease management variables such as persistent COVID-19 symptoms at 3 months, all with the aim of characterizing patients with long COVID. All patient data will be collected in a single visit.
Eligibility Criteria
Inclusion Criteria: * History of confirmed SARS-CoV-2 infection * Presentation of symptoms that have persisted for more than 3 months after SARS-CoV-2 infection * The patient reports any of the symptoms listed in the clinical assessment questionnaire or checklist. Exclusion Criteria: * The symptom(s) referred to already existed prior to acute SARS-CoV-2 infection.
Contact & Investigator
Patricia Fanlo Mateo, MD, PhD
PRINCIPAL INVESTIGATOR
Hospital Universitario de Navarra. Pamplona. Spain
Frequently Asked Questions
Who can join the NCT07417176 clinical trial?
This trial is open to participants of all sexes, studying Long COVID Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07417176 currently recruiting?
Yes, NCT07417176 is actively recruiting participants. Contact the research team at ruth.garcia.rey@navarra.es for enrollment information.
Where is the NCT07417176 trial being conducted?
This trial is being conducted at Pamplona, Spain.
Who is sponsoring the NCT07417176 clinical trial?
NCT07417176 is sponsored by Fundacion Miguel Servet. The principal investigator is Patricia Fanlo Mateo, MD, PhD at Hospital Universitario de Navarra. Pamplona. Spain. The trial plans to enroll 200 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.